CG
ELAN icon

Cynosure Group’s Elanco Animal Health ELAN Stock Holding History

Cynosure Group’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Buy
+17,670
New +$432K 0.05% 124

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Cynosure Group's ELAN Position: Q1 2026 in Review

Cynosure Group opened a new position in Elanco Animal Health (ELAN) in Q1 2026: 17,670 shares worth $423K. The stake represents 0.05% of the portfolio and ranks #124 among its holdings.

515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Cynosure Group held 17,670 shares of Elanco Animal Health worth $423K as of Q1 2026.
  • Elanco Animal Health was a new Cynosure Group position in Q1 2026.
  • Elanco Animal Health made up 0.05% of Cynosure Group's portfolio in Q1 2026, its #124 holding.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.